WEX Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by WEX Inc. on June 26, 2020, with a report date of June 29, 2020. The filing addresses material definitive agreements and regulatory disclosures related to the proposed acquisition of eNett International (Jersey) Limited and Optal Limited (the "Acquisition"). The filing details amendments to financing commitments and credit agreements necessitated by ongoing litigation with the sellers regarding a Material Adverse Effect (MAE) claim stemming from the SARS-CoV-2 pandemic.
Key Financial Metrics and Capital Structure
The filing outlines significant adjustments to the Company's debt facilities and capital raising activities:
- Acquisition Financing Commitment: The aggregate commitment remains at $1,352,000,000. The structure was reallocated from a $1,052,000,000 term loan B and $300,000,000 unsecured bridge facility to a $752,000,000 term loan B and a $600,000,000 senior secured bridge facility.
- Private Placement: The Company agreed to issue $310,000,000 in convertible notes and sell $90,000,000 in common stock to an affiliate of Warburg Pincus LLC.
- Incremental Debt Capacity: The Ninth Amendment to the Credit Agreement increased the capacity to incur additional incremental debt facilities to $1,357,000,000.
- Liquidity Requirements: The Company is required to maintain unrestricted cash and revolver availability of at least $752,000,000 (the "Minimum Availability Amount").
- Financial Covenants: The maximum consolidated leverage ratio maintenance covenant was increased to 5.50 to 1.00, with step-downs to 5.00 and 4.50 in future years. The minimum interest coverage ratio maintenance covenant was reduced to 2.75 to 1.00 in certain circumstances.
The filing does not provide specific revenue, profit, or cash flow figures for the reporting period.
Material Changes and Litigation Status
The primary material change involves the restructuring of financing terms to comply with obligations under the Share Purchase Agreement while litigation is pending. WEX Inc. has concluded that the pandemic caused a Material Adverse Effect on the target companies, disproportionate to the industry, and notified the sellers that it is not required to close the Acquisition. Consequently, the sellers initiated legal proceedings in the High Court of Justice of England and Wales seeking specific performance. The amendments to the commitment letter and credit agreement are intended to ensure compliance with financing obligations during this litigation.
Outlook, Risks, and Management Commentary
Management intends to vigorously defend against the sellers' claims and maintains its position that a Material Adverse Effect has occurred. The filing includes a Safe Harbor for forward-looking statements, highlighting several risks:
- The outcome of the pending litigation with the sellers.
- Whether the Company is ultimately required to consummate the Acquisition.
- The risk that the Private Placement or required financing is delayed or not completed.
- Potential adverse reactions to business or employee relationships due to the acquisition announcement and litigation.
- Unexpected costs or charges resulting from the proposed Acquisition and associated legal proceedings.
Key Facts for Investor Verification
- Verify the current status of the litigation in the High Court of Justice of England and Wales regarding the Material Adverse Effect claim.
- Confirm the closing status of the $310 million convertible note and $90 million common stock private placement with Warburg Pincus.
- Monitor the Company's ability to maintain the $752 million Minimum Availability Amount under the amended Credit Agreement.
- Review the impact of the increased leverage ratio covenant (5.50 to 1.00) on future financial flexibility.
- Assess the potential financial impact of legal fees and unexpected costs associated with the acquisition dispute.